Muscle Energy Technique With and Without Patellar Inferior Glide in Patients With Patellofemoral Pain Syndrome
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 3, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment called Muscle Energy Technique (MET) to help people with patellofemoral pain syndrome (PFPS), a common cause of knee pain often seen in active teens and adults. The study will compare MET alone to MET combined with a specific knee movement called patellar inferior glide, to see which method works better in reducing knee pain and improving function.
The study is open to adults aged 20 to 40 who have moderate knee pain (rated between 4 and 6 out of 10) and specific signs like a higher-than-normal kneecap position and tightness in certain thigh muscles. People with a history of knee dislocation, arthritis, recent knee surgery, fractures, or those taking certain pain medications won’t be eligible. Participants can expect to receive hands-on treatment techniques focused on improving knee movement and muscle balance. This study is not yet recruiting but aims to help find better ways to treat knee pain for those with PFPS.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals with age 20-40Years
- • Pain rating \> 3 and \< 7 on NPRS
- • Patella alta confirmed with ISI (Insall Salvati index) ratio \> 1.2 on lateral knee radiograph
- • Positive Ely's test for rectus femoris tightness
- • Positive eccentric step test
- Exclusion Criteria:
- • History of patellofemoral dislocation
- • Knee osteoarthritis
- • Recently undergo to surgery to knee
- • Fracture in knee region
- • Positive patellar tap test for knee joint effusion
- • Lateral and medial tracking of patella
- • Patients taking NSAIDs and corticosteroids
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Multān, Punjab, Pakistan
Patients applied
Trial Officials
Samrood Akram, PhD*
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported